{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T09:13:13Z","timestamp":1773220393257,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:00:00Z","timestamp":1559779200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:00:00Z","timestamp":1559779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 101-2313-B-030-003-MY3"],"award-info":[{"award-number":["MOST 101-2313-B-030-003-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 104-2410-H-029-033-MY2"],"award-info":[{"award-number":["MOST 104-2410-H-029-033-MY2"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Altern Med"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12906-019-2529-1","type":"journal-article","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T14:03:09Z","timestamp":1559829789000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Hepato-protective effects of Glossogyne tenuifolia in Streptozotocin-nicotinamide-induced diabetic rats on high fat diet"],"prefix":"10.1186","volume":"19","author":[{"given":"Shibu Marthandam","family":"Asokan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruoh-Yuh","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsu-Han","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7700-3398","authenticated-orcid":false,"given":"Wan-Teng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,6]]},"reference":[{"issue":"7","key":"2529_CR1","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.21037\/jtd.2017.06.70","volume":"9","author":"S Yandrapalli","year":"2017","unstructured":"Yandrapalli S, Aronow WS. Cardiovascular benefits of the newer medications for treating type 2 diabetes mellitus. J Thorac Dis. 2017;9(7):2124\u201334.","journal-title":"J Thorac Dis"},{"issue":"25","key":"2529_CR2","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1161\/CIRCULATIONAHA.106.679597","volume":"115","author":"S Boudina","year":"2007","unstructured":"Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation. 2007;115(25):3213\u201323.","journal-title":"Circulation"},{"issue":"6","key":"2529_CR3","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.2337\/diabetes.51.6.1938","volume":"51","author":"L Cai","year":"2002","unstructured":"Cai L, Li W, Wang G, Guo L, Jiang Y, Kang YJ. Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway. Diabetes. 2002;51(6):1938\u201348.","journal-title":"Diabetes"},{"issue":"2","key":"2529_CR4","first-page":"206","volume":"31","author":"J Karalliedde","year":"2016","unstructured":"Karalliedde J, Gnudi L. Diabetes mellitus, a complex and heterogeneous disease, and the role of insulin resistance as a determinant of diabetic kidney disease. Nephrol Dial Transplant. 2016;31(2):206\u201313.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"2529_CR5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","volume":"39","author":"M Valko","year":"2007","unstructured":"Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39(1):44\u201384.","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"2529_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.5507\/bp.2006.014","volume":"150","author":"K Bogdanova","year":"2006","unstructured":"Bogdanova K, Poczatkova H, Uherkovaa L, Riegrova D, Rypka M, Feherb J, Marchesinic G, Vesely J. Non-alcoholic fatty liver disease (NAFLD) \u2013 a novel common aspect of the metabolic syndrome. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2006;150(1):101\u20134.","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"2529_CR7","doi-asserted-by":"publisher","first-page":"472432","DOI":"10.1155\/2013\/472432","volume":"2013","author":"S Matsuda","year":"2013","unstructured":"Matsuda S, Kobayashi M, Kitagishi Y. Roles for PI3K\/AKT\/PTEN pathway in cell signaling of nonalcoholic fatty liver disease. ISRN Endocrinol. 2013;2013:472432.","journal-title":"ISRN Endocrinol"},{"issue":"1","key":"2529_CR8","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/hep.22603","volume":"49","author":"R Vuppalanchi","year":"2009","unstructured":"Vuppalanchi R, Chalasani N. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: selected practical issues in their evaluation and management. Hepatology. 2009;49(1):306\u201317.","journal-title":"Hepatology"},{"key":"2529_CR9","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.metabol.2017.04.011","volume":"72","author":"I Reccia","year":"2017","unstructured":"Reccia I, Kumar J, Akladios C, Virdis F, Pai M, Habib N, Spalding D. Non-alcoholic fatty liver disease: a sign of systemic disease. Metabolism. 2017;72:94\u2013108.","journal-title":"Metabolism"},{"issue":"9","key":"2529_CR10","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/apt.12046","volume":"36","author":"Y Yilmaz","year":"2012","unstructured":"Yilmaz Y. Review article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions? Aliment Pharmacol Ther. 2012;36(9):815\u201323.","journal-title":"Aliment Pharmacol Ther"},{"key":"2529_CR11","doi-asserted-by":"publisher","first-page":"648915","DOI":"10.1155\/2012\/648915","volume":"2012","author":"JB Chakraborty","year":"2012","unstructured":"Chakraborty JB, Oakley F, Walsh MJ. Mechanisms and biomarkers of apoptosis in liver disease and fibrosis. Int J Hepatol. 2012;2012:648915.","journal-title":"Int J Hepatol"},{"key":"2529_CR12","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1007\/s00109-011-0790-y","volume":"89","author":"Y Jiang","year":"2011","unstructured":"Jiang Y, Zhao M, An W. Increased hepatic apoptosis in high-fat diet-induced NASH in rats may be associated with downregulation of hepatic stimulator substance. J Mol Med. 2011;89:1207\u201317.","journal-title":"J Mol Med"},{"issue":"27","key":"2529_CR13","doi-asserted-by":"publisher","first-page":"3545","DOI":"10.2174\/138161205774414510","volume":"11","author":"D Schuster","year":"2005","unstructured":"Schuster D, Laggner C, Langer T. Why drugs fail--a study on side effects in new chemical entities. Curr Pharm Des. 2005;11(27):3545\u201359.","journal-title":"Curr Pharm Des"},{"issue":"1","key":"2529_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2174\/138955709787001712","volume":"9","author":"M Lopez-Lazaro","year":"2009","unstructured":"Lopez-Lazaro M. Distribution and biological activities of the flavonoid luteolin. Mini Rev Med Chem. 2009;9(1):31\u201359.","journal-title":"Mini Rev Med Chem"},{"issue":"5","key":"2529_CR15","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1089\/jmf.2015.3549","volume":"19","author":"YN Lee","year":"2016","unstructured":"Lee YN, Hsu GS, Lin WT, Lu YF. Hypolipidemic and Antioxidative effects of Glossogyne tenuifolia in hamsters fed an Atherogenic diet. J Med Food. 2016;19(5):513\u20137.","journal-title":"J Med Food"},{"issue":"6","key":"2529_CR16","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1142\/S0192415X14500876","volume":"42","author":"YH Tien","year":"2014","unstructured":"Tien YH, Chen BH, Wang Hsu GS, Lin WT, Huang JH, Lu YF. Hepatoprotective and anti-oxidant activities of Glossogyne tenuifolia against acetaminophen-induced hepatotoxicity in mice. Am J Chin Med. 2014;42(6):1385\u201398.","journal-title":"Am J Chin Med"},{"key":"2529_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13020-017-0130-4","volume":"12","author":"JY Houng","year":"2017","unstructured":"Houng JY, Tai TS, Hsu SC, Hsu HF, Hwang TS, Lin CJ, Fang LW. Glossogyne tenuifolia (Hsiang-ju) extract suppresses T cell activation by inhibiting activation of c-Jun N-terminal kinase. Chin Med. 2017;12:9.","journal-title":"Chin Med"},{"issue":"12","key":"2529_CR18","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.1016\/j.fct.2008.09.068","volume":"46","author":"HF Hsu","year":"2008","unstructured":"Hsu HF, Houng JY, Kuo CF, Tsao N, Wu YC. Glossogin, a novel phenylpropanoid from Glossogyne tenuifolia, induced apoptosis in A549 lung cancer cells. Food Chem Toxicol. 2008;46(12):3785\u201391.","journal-title":"Food Chem Toxicol"},{"key":"2529_CR19","doi-asserted-by":"publisher","DOI":"10.1201\/9781420008968","volume-title":"Taiwanese native medicinal plants : phytopharmacology and therapeutic values","author":"TSC Li","year":"2006","unstructured":"Li TSC. Taiwanese native medicinal plants : phytopharmacology and therapeutic values. Boca Raton: CRC\/Taylor & Francis; 2006."},{"issue":"3","key":"2529_CR20","doi-asserted-by":"publisher","first-page":"278","DOI":"10.5455\/jice.20160530032814","volume":"5","author":"A Boye","year":"2016","unstructured":"Boye A, Yang Y, Asenso J, Wei W. Anti-fibro-hepatocarcinogenic Chinese herbal medicines: a mechanistic overview. J Intercult Ethnopharmacol. 2016;5(3):278\u201389.","journal-title":"J Intercult Ethnopharmacol"},{"issue":"1","key":"2529_CR21","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jep.2006.02.015","volume":"107","author":"C-L Ha","year":"2006","unstructured":"Ha C-L, Weng C-Y, Wang L, Lian T-W, Wu M-J. Immunomodulatory effect of Glossogyne tenuifolia in murine peritoneal macrophages and splenocytes. J Ethnopharmacol. 2006;107(1):116\u201325.","journal-title":"J Ethnopharmacol"},{"key":"2529_CR22","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.jep.2016.07.050","volume":"194","author":"L D-l","year":"2016","unstructured":"D-l L, F-w X. Ethnobotanical study on medicinal plants used by local Hoklos people on Hainan Island, China. J Ethnopharmacol. 2016;194:358\u201368.","journal-title":"J Ethnopharmacol"},{"issue":"10","key":"2529_CR23","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.lfs.2004.08.017","volume":"76","author":"MJ Wu","year":"2005","unstructured":"Wu MJ, Weng CY, Ding HY, Wu PJ. Anti-inflammatory and antiviral effects of Glossogyne tenuifolia. Life Sci. 2005;76(10):1135\u201346.","journal-title":"Life Sci"},{"key":"2529_CR24","volume-title":"Hypoglycemic and Antioxidative Effects of Glossogyne tenuifolia on Streptozotocin-Nicotinamide-Induced Diabetic Rats, vol. 08","author":"R-Y Wang","year":"2017","unstructured":"Wang R-Y, Huang J-H, Hsu G-S, Lin W-T, Lu Y-F. Hypoglycemic and Antioxidative Effects of Glossogyne tenuifolia on Streptozotocin-Nicotinamide-Induced Diabetic Rats, vol. 08; 2017."},{"issue":"16","key":"2529_CR25","doi-asserted-by":"publisher","first-page":"6305","DOI":"10.1021\/jf050511a","volume":"53","author":"MJ Wu","year":"2005","unstructured":"Wu MJ, Huang CL, Lian TW, Kou MC, Wang L. Antioxidant activity of Glossogyne tenuifolia. J Agric Food Chem. 2005;53(16):6305\u201312.","journal-title":"J Agric Food Chem"},{"issue":"15","key":"2529_CR26","doi-asserted-by":"publisher","first-page":"6117","DOI":"10.1021\/jf050463u","volume":"53","author":"HF Hsu","year":"2005","unstructured":"Hsu HF, Houng JY, Chang CL, Wu CC, Chang FR, Wu YC. Antioxidant activity, cytotoxicity, and DNA information of Glossogyne tenuifolia. J Agric Food Chem. 2005;53(15):6117\u201325.","journal-title":"J Agric Food Chem"},{"issue":"2","key":"2529_CR27","doi-asserted-by":"publisher","first-page":"224","DOI":"10.2337\/diab.47.2.224","volume":"47","author":"P Masiello","year":"1998","unstructured":"Masiello P, Broca C, Gross R, Roye M, Manteghetti M, Hillaire-Buys D, Novelli M, Ribes G. Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes. 1998;47(2):224\u20139.","journal-title":"Diabetes"},{"issue":"140","key":"2529_CR28","first-page":"29350","volume":"49","author":"Health USNIo","year":"1984","unstructured":"Health USNIo. Laboratory animal welfare; proposed U.S. government principles for the utilization and care of vertebrate animals used in testing, research and training. Fed Regist. 1984;49(140):29350\u20131.","journal-title":"Fed Regist"},{"key":"2529_CR29","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.jff.2014.08.003","volume":"11","author":"WD Chiang","year":"2014","unstructured":"Chiang WD, Shibu MA, Lee KI, Wu JP, Tsai FJ, Pan LF, Huang CY, Lin WT. Lipolysis-stimulating peptide-VHVV ameliorates high fat diet induced hepatocyte apoptosis and fibrosis. J Funct Foods. 2014;11:482\u201392.","journal-title":"J Funct Foods"},{"issue":"8","key":"2529_CR30","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.2337\/dc10-zb08","volume":"33","author":"ZT Bloomgarden","year":"2010","unstructured":"Bloomgarden ZT. World congress on the insulin resistance syndrome, 2009: cellular mechanisms of insulin resistance. Diabetes Care. 2010;33(8):e103\u20138.","journal-title":"Diabetes Care"},{"issue":"6","key":"2529_CR31","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","volume":"54","author":"M Brownlee","year":"2005","unstructured":"Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54(6):1615\u201325.","journal-title":"Diabetes"},{"issue":"4","key":"2529_CR32","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4239\/wjd.v4.i4.101","volume":"4","author":"B Roy","year":"2013","unstructured":"Roy B. Biomolecular basis of the role of diabetes mellitus in osteoporosis and bone fractures. World J Diabetes. 2013;4(4):101\u201313.","journal-title":"World J Diabetes"},{"issue":"3","key":"2529_CR33","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/dmr.5610010304","volume":"1","author":"JM Amatruda","year":"1985","unstructured":"Amatruda JM, Livingston JN, Lockwood DH. Cellular mechanisms in selected states of insulin resistance: human obesity, glucocorticoid excess, and chronic renal failure. Diabetes Metab Rev. 1985;1(3):293\u2013317.","journal-title":"Diabetes Metab Rev"},{"issue":"1","key":"2529_CR34","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.trsl.2015.08.011","volume":"167","author":"H Khodabandehloo","year":"2016","unstructured":"Khodabandehloo H, Gorgani-Firuzjaee S, Panahi G, Meshkani R. Molecular and cellular mechanisms linking inflammation to insulin resistance and beta-cell dysfunction. Transl Res. 2016;167(1):228\u201356.","journal-title":"Transl Res"},{"issue":"2","key":"2529_CR35","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1172\/JCI10583","volume":"106","author":"GI Shulman","year":"2000","unstructured":"Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest. 2000;106(2):171\u20136.","journal-title":"J Clin Invest"},{"issue":"2","key":"2529_CR36","first-page":"84","volume":"12","author":"G Cotrozzi","year":"1997","unstructured":"Cotrozzi G, Casini Raggi V, Relli P, Buzzelli G. Role of the liver in the regulation of glucose metabolism in diabetes and chronic liver disease. Ann Ital Med Int. 1997;12(2):84\u201391.","journal-title":"Ann Ital Med Int"},{"issue":"3","key":"2529_CR37","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","volume":"34","author":"G Vernon","year":"2011","unstructured":"Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34(3):274\u201385.","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"2529_CR38","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.amjmed.2007.03.025","volume":"120","author":"IJ Hickman","year":"2007","unstructured":"Hickman IJ, Macdonald GA. Impact of diabetes on the severity of liver disease. Am J Med. 2007;120(10):829\u201334.","journal-title":"Am J Med"},{"issue":"3","key":"2529_CR39","first-page":"455","volume":"51","author":"JM Petit","year":"2014","unstructured":"Petit JM, Hamza S, Rollot F, Sigonney V, Crevisy E, Duvillard L, Raab JJ, Bronowicki JP, Bernard-Chabert B, Di Martino V, et al. Impact of liver disease severity and etiology on the occurrence of diabetes mellitus in patients with liver cirrhosis. Acta Diabetol. 2014;51(3):455\u201360.","journal-title":"Acta Diabetol"},{"issue":"6712","key":"2529_CR40","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/25248","volume":"396","author":"DR Green","year":"1998","unstructured":"Green DR. Apoptosis. Death deceiver. Nature. 1998;396(6712):629\u201330.","journal-title":"Nature"},{"key":"2529_CR41","first-page":"11","volume":"2013","author":"J Xiao","year":"2013","unstructured":"Xiao J, Guo R, Fung M-L, Liong EC, Chang RCC, Ching Y-P, Tipoe GL. Garlic-derived S-Allylmercaptocysteine ameliorates nonalcoholic fatty liver disease in a rat model through inhibition of apoptosis and enhancing autophagy. Evid Based Complement Alternat Med. 2013;2013:11.","journal-title":"Evid Based Complement Alternat Med"},{"key":"2529_CR42","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.2741\/1765","volume":"10","author":"AE Feldstein","year":"2005","unstructured":"Feldstein AE, Gores GJ. Apoptosis in alcoholic and nonalcoholic steatohepatitis. Front Biosci. 2005;10:3093\u20139.","journal-title":"Front Biosci"},{"issue":"2","key":"2529_CR43","first-page":"878","volume":"9","author":"MT Park","year":"2003","unstructured":"Park MT, Kang JA, Choi JA, Kang CM, Kim TH, Bae S, Kang S, Kim S, Choi WI, Cho CK, et al. Phytosphingosine induces apoptotic cell death via caspase 8 activation and Bax translocation in human cancer cells. Clin Cancer Res. 2003;9(2):878\u201385.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2529_CR44","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1142\/S0192415X07004631","volume":"35","author":"TH Lin","year":"2007","unstructured":"Lin TH, Ng LT, Yen FL, Lin CC. Hepatoprotective effects of chai-Hu-Ching-Kan-tang on acetaminophen-induced acute liver injury in rats. Am J Chin Med. 2007;35(1):69\u201379.","journal-title":"Am J Chin Med"},{"issue":"16","key":"2529_CR45","doi-asserted-by":"publisher","first-page":"6305","DOI":"10.1021\/jf050511a","volume":"53","author":"M-J Wu","year":"2005","unstructured":"Wu M-J, Huang C-L, Lian T-W, Kou M-C, Wang L. Antioxidant activity of Glossogyne tenuifolia. J Agric Food Chem. 2005;53(16):6305\u201312.","journal-title":"J Agric Food Chem"},{"issue":"2","key":"2529_CR46","doi-asserted-by":"publisher","first-page":"188","DOI":"10.5152\/balkanmedj.2011.030","volume":"29","author":"H Birman","year":"2012","unstructured":"Birman H, Dar KA, Kapucu A, Acar S, Uz\u00fcm G. Effects of Luteolin on liver, kidney and brain in Pentylentetrazol-induced seizures: involvement of metalloproteinases and NOS activities. Balkan medical journal. 2012;29(2):188\u201396.","journal-title":"Balkan medical journal"},{"issue":"4","key":"2529_CR47","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.bbrc.2016.11.101","volume":"482","author":"Y Yin","year":"2017","unstructured":"Yin Y, Gao L, Lin H, Wu Y, Han X, Zhu Y, Li J. Luteolin improves non-alcoholic fatty liver disease in db\/db mice by inhibition of liver X receptor activation to down-regulate expression of sterol regulatory element binding protein 1c. Biochem Biophys Res Commun. 2017;482(4):720\u20136.","journal-title":"Biochem Biophys Res Commun"}],"container-title":["BMC Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-019-2529-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12906-019-2529-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-019-2529-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T23:06:03Z","timestamp":1591311963000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-019-2529-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,6]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2529"],"URL":"https:\/\/doi.org\/10.1186\/s12906-019-2529-1","relation":{},"ISSN":["1472-6882"],"issn-type":[{"value":"1472-6882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,6]]},"assertion":[{"value":"15 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experimental protocols were reviewed and approved by the Animal Experimental Committee of Fu Jen University (IACUC No. A10056), and the study was conducted in accordance with the U.S. government principles for the utilization and care of vertebrate animals used in testing, research and training.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"117"}}